-
JAMA dermatology (Chicago, Ill.). 04/2013; 149(4):491-493.
-
International journal of dermatology 08/2012; 51(10):1239-41. · 1.18 Impact Factor
-
The Journal of pediatrics 05/2012; 161(4):768. · 4.02 Impact Factor
-
The Journal of pediatrics 05/2012; 161(4):766. · 4.02 Impact Factor
-
Enfermedades Infecciosas y Microbiología Clínica 02/2012; 30(2):99-100. · 1.49 Impact Factor
-
Medicina 01/2012; 72(1):44. · 0.47 Impact Factor
-
Journal of the American Academy of Dermatology 07/2011; 65(1):238-9. · 3.99 Impact Factor
-
Enfermedades Infecciosas y Microbiología Clínica 12/2010; 29(1):68-9. · 1.49 Impact Factor
-
Journal of the American Academy of Dermatology 11/2010; 63(5):908-9. · 3.99 Impact Factor
-
Acta Dermato-Venereologica 10/2010; 91(1):108, 110.
-
Canadian Medical Association Journal 08/2010; 182(11):E533. · 8.22 Impact Factor
-
Sexually transmitted diseases 07/2010; 37(7):467. · 2.58 Impact Factor
-
Medicina Clínica 11/2009; 136(1):44. · 1.38 Impact Factor
-
Medicina Clínica 10/2009; 135(4):193. · 1.38 Impact Factor
-
Medicina Clínica 01/2009; 131(20):800. · 1.38 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Spain has one of Europe's lowest melanoma incidence and mortality rates. Nevertheless, it is one of the fastest-growing pathologies in our country, with a 181.3% increase in the incidence rate in men and 205.3% increase in women. It represents 1.3% and 2.5% of malignant tumors in men and women, respectively, while the current standardized worldwide rate is respectively 2.4% and 4.9%. The highest incidence levels correspond to Tarragona for men (6.81%) and Gerona for women (8.24%), and lowest to the Canary Islands and Zaragoza (3.55% and 4.27% for women and men, respectively). This higher incidence among females differentiates Spain from the rest of Europe, where the opposite occurs. Mortality has also increased in Spain in the last few decades (1.76% in males and 1.26% in females), although this rising trend has stabilized in recent years. Spain's mortality rate is the lowest in Europe, as the EUROCARE-III study revealed. This study found an increase of 70.4% in the survival rate for men and 84.1% for women in the 1980s, while the figures for the 1990s were 73.9% for men and 89.8% for women. This low mortality rate in Spain may be due to the increase in thin melanomas, due to early diagnosis and surgical treatment.
Actas Dermo-Sifiliográficas 10/2005; 96(7):411-8.
-
[show abstract]
[hide abstract]
ABSTRACT: In the year 2000, the European Academy of Dermatology and Venereology initiated a campaign, called "Euromelanoma Day," for the early detection of melanoma.
To discuss the results of "Euromelanoma Day" in Spain for the campaigns carried out in 2000, 2001 and 2002.
Participating members of the Spanish Academy of Dermatology examined everyone who requested an appointment, free of charge, in order to detect suspicious lesions. Four months after the visit, telephone contact was made with all patients who had been diagnosed with suspected melanoma to ask them whether the lesions had been excised, and if so, the result of the histological study of the specimen.
33,750 calls to set up an appointment were received, and 12,487 patients were examined. The average participation by dermatologists was 399 academy members per year. A total of 164 lesions suspected of being melanoma were detected, above all in Andalusia and Catalonia, and the diagnosis was histologically confirmed in 31 cases. The clinicopathological correlation was 23.3 %, a higher figure than the one for the USA and similar to the one for Mediterranean countries. The average thickness of the tumors was 0.93 mm.
Although these campaigns have the drawback of possible bias in the findings and may cause some degree of public alarm, the benefit to the population was unquestionable in terms of heightening awareness of a health problem.
Actas Dermo-Sifiliográficas 06/2005; 96(4):217-21.
-
[show abstract]
[hide abstract]
ABSTRACT: Cheilitis granulomatosa (CG) is a rare, idiopathic inflammatory disorder that usually affects young adults and clinically is characterized by diffuse, non-tender, soft to firm swelling of one or both lips. A variant of granulomatous cheilitis is Melkersson-Rosenthal syndrome when associated with facial paralysis and furrowed tongue. Several treatments have been used with variable success. We report 3 cases of GC treated with oral clofazimine 100 to 200 mg daily for 3 to 6 months obtaining regression of lesions in all treated cases. Hyperpigmentation and elevation of liver enzymes were observed as side effects.
Journal of drugs in dermatology: JDD 4(3):374-7. · 1.57 Impact Factor
